Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
May
23
2019
Beef Industry Reeks of Collusion, Plaintiffs Allege Bilzin Sumberg
May
23
2019
Spotlight On Private Equity in the Fertility Sector McDermott Will & Emery
May
23
2019
The Role of Patient Preference in Medical Device Evaluation Epstein Becker & Green, P.C.
May
23
2019
Washington State Bill Creates Standards for Labeling of Compostable Food Packaging Keller and Heckman LLP
May
23
2019
Legislature Significantly Amends the West Virginia Medical Cannabis Act Steptoe & Johnson PLLC
May
22
2019
Roll Up, Roll Up: ‘Cannabis Inc.’ Is Open for Business, but UK Investors Must Wait Their Turn Greenberg Traurig, LLP
May
22
2019
Louisiana Bill Would Require Shrimp and Crawfish Country Of Origin Labeling on Restaurant Menus Keller and Heckman LLP
May
22
2019
Hemp, CBD, and Marijuana: What's the Difference? von Briesen & Roper, s.c.
May
22
2019
340B Rate Cuts: DC Court Enjoins and Remands CMS’ 2018 and 2019 Reductions for Hospital Outpatients Foley & Lardner LLP
May
21
2019
EU: The Council Adopts New Rules on Single-use Plastics Keller and Heckman LLP
May
21
2019
FDA Extends Application Deadline for VQIP Keller and Heckman LLP
May
21
2019
EC Publishes Recommendation on Coordinated Control Plan for Certain Substances Migrating from FCMs Keller and Heckman LLP
May
21
2019
NIOSH Activities at 2019 AIHce EXP Include Presentations on Nanomaterials Bergeson & Campbell, P.C.
May
21
2019
The Opioid Crisis Costs Billions: Will Insurance Pay for It? (Part 1) Gilbert LLP
May
20
2019
Location Matters – Manufacturing Insights from FDA’s Annual Report on Drug Quality Sheppard, Mullin, Richter & Hampton LLP
May
20
2019
Suit Over Use of American Heart Association Certification Mark Maintains a Pulse Proskauer Rose LLP
May
20
2019
California Poised to Remove Prohibition on Hemp-Derived CBD in Foods and Supplements Wilson Elser Moskowitz Edelman & Dicker LLP
May
20
2019
Federal Circuit Invalidates Patented Cancer Therapy Foley & Lardner LLP
May
20
2019
Arbitration Clause in Beer Distribution Agreement Enforced by the Virginia ABC McDermott Will & Emery
May
20
2019
Industry Guidance on Food Contact Paper Updated Keller and Heckman LLP
May
20
2019
FDA Greenlights Use of “Potassium Chloride Salt” as an Alternative Name for “Potassium Chloride” in Food Labeling Keller and Heckman LLP
May
18
2019
Slides Available from ACS Webinar on Working Safely with Nanomaterials in the Laboratory Bergeson & Campbell, P.C.
May
17
2019
New York City Bars Pre-employment Marijuana Testing Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
May
17
2019
Wait a New York Minute – Is California’s Prop 65 Chemical Warning Statute Making its Way out East? Polsinelli PC
May
17
2019
FDA Issues In Final Guidance On Interchangeable Biosimilars Bergeson & Campbell, P.C.
May
17
2019
New Rules for the Labelling, Production and Protection of Spirit Drinks. Keller and Heckman LLP
May
17
2019
Neste Announces Sustainable Menu For Zero Island Bergeson & Campbell, P.C.
May
17
2019
Sixth Circuit Vacates Convictions Due to “Flagrant Misconduct” by Prosecutor Squire Patton Boggs (US) LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins